Attached files
| file | filename |
|---|---|
| EX-32.2 - EX-32.2 - Crinetics Pharmaceuticals, Inc. | crnx-ex322_9.htm |
| EX-32.1 - EX-32.1 - Crinetics Pharmaceuticals, Inc. | crnx-ex321_7.htm |
| EX-31.2 - EX-31.2 - Crinetics Pharmaceuticals, Inc. | crnx-ex312_6.htm |
| EX-31.1 - EX-31.1 - Crinetics Pharmaceuticals, Inc. | crnx-ex311_11.htm |
| EX-4.3 - EX-4.3 - Crinetics Pharmaceuticals, Inc. | crnx-ex43_10.htm |
| 10-K - 10-K - Crinetics Pharmaceuticals, Inc. | crnx-10k_20201231.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
Crinetics Pharmaceuticals, Inc.
San Diego, California
We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (No. 333-233246) and Form S-8 (No. 333-226234) of Crinetics Pharmaceuticals, Inc., of our report dated March 30, 2021, relating to the consolidated financial statements, which appears in this Annual Report on Form 10-K.
/s/BDO USA, LLP
San Diego, California
March 30, 2021